Research Projects


In order to strengthen your profile so to have better opportunities in your career, i. e, for jobs or for higher studies you need to have good publications under your belt. The only program since 2010 which is fulfilling this need is the Research Project Training Program of BDG LifeSciences (OPC) Pvt. Ltd. which is of novel research projects on the latest technologies of Bioinformatics. 

In this program, we implement the current research trend and apply unique ways of teaching plus practical application so to make you learn in the best possible way. As it is done online hence participants have the freedom of choosing the time of training sessions according to their choice and also save a huge amount of money in travel, accommodation, food, etc., As of now we have completed more than 60 research projects and all of them published at International level. This research project can be done as a Major and/or thesis project for the final year or if someone wants to strengthen their profile. You can view all the completed projects hereTo view the video feedback of our previous events kindly visit our YouTube Channel To view, the teams for current projects click here


CURRENT RESEARCH PROJECT- MAJOR/DISSERTATION PROJECT

Applications are invited for 5 SEATS in our 67 novel research project entitled "Study of SARS-CoV-2 main protease (Mpro) and derivatives of Norterihanin to investigate potential inhibitors using Virtual Screening & Molecular Docking"

DURATION: 3-4 Months- training sessions will be conducted online according to the date and time you choose.

FEE: In India Online: 20000 INR, Foreign Online: 399 US $

Topics which will be covered are:

  • Introduction of Molecular Modeling & Drug Discovery
  • Drug Target Analysis- SARS-CoV-2 main protease (MPro)
  • Virtual Screening on the basis of structure similarity of Norterihanin
  • In-silico generation of novel ligands- Molecular Editing
  • Conversion of files- .mol to .pdb
  • Protein Optimization
  • Energy Minimization
  • Molecular Docking- Creation of .gpf and .dpf files
  • Algorithm-autogrid & autodock
  • Selection of inhibitors on the basis of delta G.
  • Structure Analysis/ H-bond/Atomic-level studies
  • Prediction of Molecular Properties
  • Prediction of Bioactivity
  • ADMET- Bioavailability-LD 50-AMES Test, etc
  • Drug Likeness

OUTCOME: At the end of the study we would be able to get molecules that would show the best binding affinity to the biological target as well as ready to be checked for further PK/PD studies. After the successful completion of the project, it will be submitted for international publication by the names of people who will work on this project.

WHAT YOU GET:

  • Training in Drug Discovery & Designing. Opportunity to work on a novel research project. Practical application of training.
  • Software, which you can use for other projects.
  • Tutorial and Papers of technology. So to make you understand every aspect of the technology.
  • Publication of the project by your name at International Level in the form of Paper/ Oral/ Poster/ Abstract.
  • Certificates of Training & Research Project.
  • Recommendation letter for Job/PhD.
  • Add the position of Research Project Trainee in your CV and LinkedIn profile. This will serve the purpose of work experience.
  • We will connect you with people in our group who did projects with us which will help you in getting jobs as well as PhD positions around the world.

T & C:

  • Only Windows OS is required for training & software installation.
  • Once you register and pay the fee we will send you a welcome email having details to prepare your system and installation of the software. Information of molecules (dataset of molecules) on which you have to work. Files and papers of technology as well as of project.
  • Once registration is done it is NON-REFUNDABLE/NON TRANSFERABLE.
  • Once you prepare your system and tell us when to conduct your training session and do not turn up then we will send you the steps of that phase.
  • Timings are to be strictly followed.
  • The certificate will be given only when you complete all the tasks of the project, which means 5 phases.
  • While you will be working on the project and completing the tasks to monitor the progress of your work you have to send daily project reports to your guide.
  • You will be directly connected to your guide as well as in a group where people who have completed their research project with us are present to solve your queries as the earliest.

TEAM FOR CURRENT/ONGOING RESEARCH PROJECTS

66. Molecular Modelling study of SARS-CoV-2 spike protein of COVID-19 with derivatives of Saikosaponins | Examining the anticoronaviral activity of saikosaponins (A, B2, C and D)

  1. Amisha Garg, System Biology and Bioinformatics, Panjab University, Chandigarh, India. 
  2. Sweta Mohanty, Department of Biotechnology, KIIT University, India.
  3. Rudra Prasad Nayak, Department of Biotechnology, KIIT University, India.
  4. Suparna Giri, Department of Biotechnology, KIIT University, India.
  5. Aakash Deva T.P, School of Bioengineering, SRMIST, Chennai, India.

65. Molecular Modeling study of Southeast Asian Medicinal Plant Aglaia erythrosperma  and α-D-glucose-1-phosphate thymidylyltransferase (Mycobacterium-RmlA) | Discovery of new drugs for multidrug-resistant (MDR) Mtb

  1. Arka Sanyal, Department of Biotechnology, KIIT University, Bhubaneshwar, Odisha, India.
  2. Ankita Mohanty, Department of Biotechnology, KIIT University, Bhubaneshwar, Odisha, India
  3. Saswat Dash, Department of Biotechnology, KIIT University, Bhubaneshwar, Odisha, India
  4. Aditi Rubal, Department of Biotechnology, KIIT University, Bhubaneshwar, Odisha, India
  5. Anusakha Panigrahi, Department of Biotechnology, KIIT University, Bhubaneshwar, Odisha, India
  6. Adrija Dihingia, Department of Biotechnology, KIIT University, Bhubaneshwar, Odisha, India

64.Molecular Modeling study of Cyclophilin A and derivatives of 1,8-Diamino-2,4,5,7-tetrachloroanthraquinone: Design of novel inhibitors for Cyclophilin A 

  1. Safiya Aafreen, Biomedical Engineering, Johns Hopkins University , Baltimore, USA.
  2. Jyothi Giridhar, Narayana Pharmacy College, JNTU Anantapur, India.
  3. Sanica Nadkarni, MGM Institute of Health Sciences, India.
  4. Ankita Saha, Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee(IITR), Roorkee, Uttarakhand, India.
  5. Nirav Parmar, Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee(IITR), Roorkee, Uttarakhand, India.
  6. Manjari Gaur, Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee(IITR), Roorkee, Uttarakhand, India.

63. Molecular Modelling study of Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis | Discovery of new Anti-Tubercular Drugs

  1. P Ansuman Abhisek, MKCGMCH, Odisha, India.
  2. Chitra Roy, Ballygunge Science College, University of Calcutta, Kolkata, India.
  3. Ramya Vishwanathan, Biotechnology Engineering, SRM Institute Of Science And Technology, India.
  4. Niyati Bisht, Department of Immunology and Virology, Amity University, Noida, India.
  5. Mudita Appasaheb Kadam, Maulana Abul Kalam Azad University of Technology, Kolkata, West Bengal, India. 

62. Molecular Modelling study of p53-MDM2 | Discovery of new Anti-CANCER Drugs by Molecular Docking & MD Simulations Approach

  1. Ngoc Pham, The Applied Chemistry Department of the International University, Ho Chi Minh, Vietnam.
  2. Remya Prajeshgopal, Virology Department, Emirates Modern Poultry Co(Al Rawdah), Dubai, UAE.
  3. Shibam Dey, B.Tech+ M. Tech Biotechnology Dual Degree, KIIT University Bhubaneshwar,Odhisa, India
  4. Shalini Susmita, B.Tech+ M. Tech Biotechnology Dual Degree, KIIT University Bhubaneshwar,Odhisa, India.
  5. Anurag Chatterjee, B.Tech+ M. Tech Biotechnology Dual Degree, KIIT University Bhubaneshwar,Odhisa, India.

61. Molecular modeling of sphingosine 1-phosphate receptor 1(S1P1) as target for multiple sclerosis | A Virtual screening, Molecular docking & ADMET study

  1. Veera Raghava Choudary Palacharla, Scientist, Drug Discovery, M.Pharmacy, Annamalai University, India.
  2. Dr Arul Amuthan, Division of Siddha, Center for Integrative Medicine and Research (CIMR), Manipal University, India.
  3. Sandip Jaiswal, Operations manager (Cloud Platform), CSC, India.
  4. Manika Gupta, Master of Science in Genomics, Amity Institute of Virology and Immunology, Amity University, India.
  5. Dhanush R A, B. Tech - Genetic engineering, SRM Institute of Science and Technology, India.
  6. Poonam Dhiman, BS-MS Integrated Course, Indian Institute of Science Education and Research, Mohali, India.
  7. Preethi Varriar, Bachelor of Technology (B. Tech), Biotechnology, Delhi Technological University, India
  8. Mohammad Khan, Masters of Science in Bioinformatics, G.N Khalsa College, Matunga, Mumbai, India
  9. Shagufta Khan, Masters of Science in Bioinformatics, G.N Khalsa College, Matunga, Mumbai, India.

60. Inhibitory study of α-D-glucose-1-phosphate thymidylyltransferase (Mycobacterium-RmlA) | Discovery of new drugs for multidrug-resistant (MDR) Mtb

  1. Prof. Dr. Ali Abdulhafidh Ibrahim Al-Shaikhli, Department of Mathematical and applied computer, College of Science, Al-Nahrain University, Jadriyah, Baghdad, Iraq.
  2. Dr. Prince Prashant Sharma,Gurukula Kangri Vishwavidyalaya, Department of Pharmaceutical Sciences, Haridwar, India.
  3. Gauri Kiran Vanjari, Bachelor of Dental Surgery, SASS Yogita Dental College and Hospital, Maharashtra University of health Sciences, Nasik, India.
  4. Shivam Bhan, B.Tech Biotechnology, Amity University, Noida, UP, India.

59. Molecular modeling study of derivatives of dutasteride and Human Steroid 5β-Reductase (AKR1D1) | Discovery of new drugs for prostate cancer

  1. Chhavi Rai, BDG LifeSciences, India.
  2. Vinay Kumar, BDG LifeSciences, India
  3. Dipjyoti Dey, Master of Science Applied Microbiology, Vellore Institute of Technology (VIT) University, Vellore, India.
  4. Mehuli Mishra, B.Sc, Department of Biotechnology, Jyoti Nivas College, Bengaluru, India
  5. Vidushi Aggarwal, B.Sc, Department of Biotechnology, Jyoti Nivas College, Bengaluru, India.
  6. Disha Mitra, Biophysics, Molecular Biology and Bioinformatics, Rajabazar Science College, Calcutta University, India.
  7. Suparna Maji, B.Tech M.Tech Dual Degree in Biotechnology, KIIT University, Bhubaneswar, Odisha, India
  8. Soumyadipta Das, B.Tech M.Tech Dual Degree in Biotechnology, KIIT University, Bhubaneswar, Odisha, India
  9. Suman Nayek, B.Tech M.Tech Dual Degree in Biotechnology, KIIT University, Bhubaneswar, Odisha, India.
  10. Subarna Chakraborty, B. Tech Genetic Engineering, SRM Institute of Science and Technology, India.

57. Molecular modeling study of α-glucosidase Inhibitors (AGIs) | Discovery of new anti-diabetic drugs by controlling postprandial hyperglycemia

  1. Dr Minakshi Garg PhD, Assistant Professor in Biotechnology, University Institute of Engineering and Technology, Panjab University Chandigarh, India
  2. M. Raghanivedha, Master of science in Biotechnology, Seattle, Washington, United States of America.
  3. Shreya Mondal, B. Tech (Biotechnology), Amity University, Noida, India.
  4. H. Vijayasri, B.Sc. (Hons) Biomedical Sciences at Sri Ramachandra Institute of Higher Education and Research (DU) Porur, Chennai.
  5. Nikita Yadav, BS-MS Integrated Course, Indian Institute of Science Education and Research, Mohali, India
  6. Sucharita Ghosh, B.Tech M.Tech Dual Degree in Biotechnology, KIIT University, Bhubaneswar, Odisha, India.

56. Discovery of new ligands for PPAR Gamma responsible for Diabetes Type 2: A Virtual Screening, Docking & ADMET Study.

  1. Bharti Mittal, PhD, Senior Scientist, Operations, MedGenome Labs Pvt Ltd, Bangalore, India.
  2. Vivek Srivastava, Ph.D., Assistant Professor(Biochemistry), School of Basic Sciences and Research, Sharda University, Greater Noida, UP
  3. Maitili Varma, Advanced Proficiency course in Genetic engineering, Genohelix Biolabs, Jain Group of Institutions, India.
  4. Priyadarshini Sharma, B. Tech, Amity Institute of Biotechnology, Amity University, Noida, India.
  5. Harshita Agarwal, B. Sc, Amity Institute of Biotechnology, Amity University, Noida , India.
  6. Gupta Radha Devi Shivprakash, Masters of Science in Bioinformatics, G.N Khalsa College, Matunga, Mumbai, India
  7. Raisa Dabhilkar, Masters of Science in Bioinformatics, G.N Khalsa College, Matunga, Mumbai, India.

53. Molecular Modelling study of phytoconstituents from medicinal plants of India | Discovery of natural anti-tubercular agents

  1. Taiba Hamed Youssef Gamal El Din, Master in Biotechnology & Life Science, Bani Sueif University, Bani Sueif, Egypt.
  2. Syeda Birjees Misbah, M.Sc., Biochemistry, REVA University, Bangalore, India.
  3. Aindrila Pal, B. Tech, Amity Institute of Biotechnology, Amity University, Noida, India.
  4. Preeti, M.Sc Biotech, Amity Institute of Biotechnology, Amity University, India.
  5. Ngoc Pham, The Applied Chemistry Department of the International University, Ho Chi Minh, Vietnam.
  6. Moumita Ganguly, Research Associate, IIT Mandi, India.
  7. Deeksha Gairola, M.Sc Biotech, Amity Institute of Biotechnology, Amity University, India.
  8. Ketaki Ghatole, B.E. Biotechnology, MS Ramaiah Institute of Technology, Bengaluru, India.

49. Molecular Modeling study of Zika Virus | Virtual Screening, Protein Modeling, Docking, ADMET and MD Simulations Study

  1. Dr. Alam El-Din, Hanaa Mahmoud, Virology and Immnunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  2. Manjisa Choudhury, VIT University, Vellore, India.
  3. Nada Gamal Ibrahim El-Dawy, Faculty of Biotechnology, October University for Modern Sciences and Arts, Egypt (MSA University).

39. Study of derivatives of Chalcones as new Tyrosinase inhibitors: A Molecular Docking, ADME & Tox Study

  1. Adwaita Das, Department of Botany, The University of Burdwan, Burdwan, West Bengal, India
  2. Shreya John MSc Bioinformatics, St. Aloysius Institute of Management and Technology, Mangalore University.
  3. Lalit R. Samant, Project Assistant, Haffkine Institute for Training Research and Testing, India.
  4. K.C. Haritah Yadav, M. Sc (Medical Pharmacology) from Kamineni Institute of Medical Sciences, Narkrtpally, Nalgonda, Andhra Pradesh.
  5. Dr. N. Hari, School of Chemical & Biotechnology, SASTRA University, Thanjavur, Tamil Nadu.
  6. Dr(Mrs) Jhaumeer Laulloo Sabina, University of Mauritius, Reduit, Mauritius.

34. Study of extracts of Veratrum Dahuricum as potential Anti-tumor molecules: Molecular Docking & Modeling study with Farnesyl Pyrophosphate Synthase (FFPS)

  1. Gomathi Rajendran, ITC Zenith (M) Sdn. Bhd. (Conformity Assessment Body), Malaysia.
  2. Seetha Harilal, Department of Pharmacology, Nehru College of Pharmacy, Kerala University of Health Sciences, Thrissur, Kerala, India.
  3. Akshya Kumar Mailapali, I. M.Sc Bioinformatics , B.J.B. Autonomous College, Utkal University, Bhubaneshwar, India.
  4. Tanya Munjal, M.Sc Biotech, Amity Institute of Biotechnology, Amity University, India.
  5. Sambit Kumar Roy, M.Sc Biotech, Amity Institute of Biotechnology, Amity University, India.
  6. Lucky Gupta, M.Sc Biotech, Amity Institute of Biotechnology, Amity University, India.
  7. Gaurav Dutt, School of Basic and Applied Science, Dayananda Sagar University, Bangalore, India.